AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
285 hedge funds and large institutions have $3.05B invested in Amedisys in 2022 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 99 increasing their positions, 106 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
1% less capital invested
Capital invested by funds: $3.07B → $3.05B (-$19.2M)
1% less funds holding
Funds holding: 287 → 285 (-2)
7% less repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 106
Holders
285
Holding in Top 10
1
Calls
$14.2M
Puts
$6.27M
Top Buyers
| 1 | +$128M | |
| 2 | +$59.9M | |
| 3 | +$20.8M | |
| 4 |
DM
Deerfield Management
New York
|
+$19.2M |
| 5 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$14.7M |
Top Sellers
| 1 | -$47.7M | |
| 2 | -$35.5M | |
| 3 | -$11.5M | |
| 4 |
Amundi
Paris,
France
|
-$11.4M |
| 5 |
Twin Tree Management
Dallas,
Texas
|
-$11.2M |